United States — National Cancer Institute
Tracked across 8 events · 56 articles · First seen May 18, 2025 · Last active Jun 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: United States — National Cancer Institute provided grants supporting the research for MethylScan, demonstrating its commitment to cancer research.
Apr 06, 2026 · 6 articles
Tech
Impact: The United States — National Cancer Institute provides funding for Qing Zhu's work on the new breast cancer imaging technology.
Apr 06, 2026 · 6 articles
Business
Impact: The United States — National Cancer Institute is sponsoring trials for iadademstat in various hematologic malignancies and solid tumors under a Cooperative Research and Development Agreement with Oryzon Genomics.
May 14, 2026 · 6 articles
Domestic
Impact: The United States — National Cancer Institute is investigating ivermectin's ability to treat cancer, but their research is preclinical and cannot yet be applied to patients.
May 12, 2026 · 7 articles
ERGEN INTELLIGENCE
Track United States — National Cancer Institute live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard